S
Shanghai OuDaXin New Material Technology Center
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E | 12 | 4.9 | 0.0 | 10.0 | 11 Aug 2025 |
| Tesamorelin | E | 8 | 5.8 | 0.0 | 9.9 | 11 Aug 2025 |
| Tirzepatide | E | 23 | 5.6 | 0.0 | 10.0 | 3 Jun 2025 |
| ACE-031 | E | 3 | 5.4 | 4.0 | 6.5 | 21 May 2026 |
| Adipotide | E | 4 | 6.3 | 4.5 | 7.5 | 24 May 2026 |
| Anavar (Oxandrolone) Raw | E | 3 | 5.6 | 3.2 | 8.2 | 24 May 2026 |
| Andarine (S-4) Raw | E | 3 | 4.0 | 0.9 | 6.3 | 17 May 2026 |
| BPC157 10mg + TB500 10mg Blend | E | 3 | 4.0 | 3.3 | 4.0 | 19 Jan 2026 |
| BPC157 5mg + TB500 5mg Blend | E | 2 | 4.5 | 3.9 | 5.0 | 24 May 2026 |
| Cerebrolysin | X | 1 | 7.0 | 7.0 | 7.0 | 8 Jul 2025 |
| Chonluten | E | 2 | 5.6 | 5.6 | 5.6 | 19 Jan 2026 |
| Drostanolone Propionate (Mast P) Raw | X | 1 | 5.0 | 5.0 | 5.0 | 2 Apr 2025 |
| EPO | E | 4 | 5.5 | 3.3 | 6.8 | 24 May 2026 |
| GHRP-6 Acetate | X | 1 | 5.4 | 5.4 | 5.4 | 24 Apr 2025 |
| Glutathione | E | 3 | 5.3 | 3.6 | 6.1 | 26 Jan 2026 |
| HGH Fragment 176-191 | X | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 |
| Hyaluronic acid | E | 3 | 6.4 | 4.0 | 9.6 | 20 May 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | E | 2 | 4.2 | 2.9 | 5.4 | 26 Jan 2026 |
| KPV Oral | X | 1 | 4.5 | 4.5 | 4.5 | 24 Apr 2025 |
| LGD-4033 (Ligandrol) | E | 3 | 6.4 | 5.5 | 7.4 | 19 Jan 2026 |
| Lipo-C 120mg | E | 4 | 5.3 | 2.5 | 7.5 | 21 May 2026 |
| Livagen | X | 1 | 5.0 | 5.0 | 5.0 | 16 Mar 2025 |
| MENT (Trestolone Acetate) | E | 2 | 5.8 | 5.4 | 6.2 | 21 May 2026 |
| MOTS-C | E | 3 | 6.4 | 4.8 | 8.7 | 21 May 2026 |
| MT-1 | E | 3 | 6.0 | 5.1 | 6.7 | 24 May 2026 |
| PE 22-28 | X | 1 | 4.5 | 4.5 | 4.5 | 28 Mar 2025 |
| Primobolan E Raw | E | 3 | 6.2 | 4.0 | 8.1 | 23 May 2026 |
| Retatrutide 30mg Pen Kit | E | 4 | 4.8 | 3.1 | 6.8 | 23 May 2026 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | E | 2 | 6.5 | 6.0 | 6.9 | 24 May 2026 |
| Selank 10mg + Semax 10mg Blend | E | 2 | 5.8 | 5.5 | 6.2 | 17 May 2026 |
| Selank | E | 3 | 6.3 | 4.9 | 7.4 | 19 Jan 2026 |
| Sildenafil (Viagra) | E | 4 | 6.4 | 5.2 | 7.6 | 20 May 2026 |
| SLU-PP-332 | E | 3 | 4.3 | 1.5 | 5.7 | 25 May 2026 |
| Superdrol Oil | E | 4 | 6.3 | 5.1 | 8.7 | 19 Jan 2026 |
| Tamoxifen (Nolvadex) Raw | X | 1 | 4.3 | 4.3 | 4.3 | 20 Jun 2025 |
| Tesofensine | E | 3 | 5.3 | 3.3 | 7.3 | 24 May 2026 |
| Test Suspension | E | 3 | 6.0 | 3.9 | 7.6 | 17 May 2026 |
| Testosterone Base Micro Raw | E | 3 | 6.1 | 5.4 | 6.6 | 23 May 2026 |
| Thymosin Alpha-1 | E | 4 | 5.3 | 4.6 | 5.7 | 17 May 2026 |
| Vesugen | E | 3 | 5.6 | 4.5 | 6.8 | 24 May 2026 |
| Winstrol Oil | X | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| YK11 | X | 1 | 4.7 | 4.7 | 4.7 | 16 Mar 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | Andarine (S-4) Raw | 4.1 | 1g | 1.2g | +17.7% | 99.05% | Lab E |
| 24 May 2026 | EPO | 4.7 | 20mg | 18.7mg | -6.6% | 98.51% | Lab C |
| 24 May 2026 | Testosterone Base Micro Raw | 6.9 | 10g | 10.7g | +6.9% | 97.31% | Lab D |
| 24 May 2026 | Thymosin Alpha-1 | 6.6 | 20mg | 23.3mg | +16.3% | 96.39% | Lab F |
| 24 May 2026 | Sildenafil (Viagra) | 6.7 | 25mg | 29.4mg | +17.7% | 99.71% | Lab B |
| 24 May 2026 | BPC157 10mg + TB500 10mg Blend | 6.0 | 10mg | 10.6mg | +6.2% | 96.87% | Lab F |
| 24 May 2026 | Lipo-C 120mg | 5.3 | 100mg/ml | 100.5mg/ml | +0.5% | 99.85% | Lab B |
| 24 May 2026 | Livagen | 5.4 | 30mg | 25.8mg | -14.1% | 99.88% | Lab F |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 7.5 | 10mg | 9.5mg | -5.1% | 96.00% | Lab E |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.2 | 50mg | 54.9mg | +9.8% | 95.02% | Lab C |
| 24 May 2026 | Testosterone Base Micro Raw | 7.5 | 500g | 620.2g | +24.0% | 98.32% | Lab F |
| 24 May 2026 | Winstrol Oil | 10.0 | 200mg/ml | 198.6mg/ml | -0.7% | 99.69% | Lab D |
| 24 May 2026 | LGD-4033 (Ligandrol) | 5.4 | 50mg | 49.3mg | -1.4% | 95.45% | Lab F |
| 23 May 2026 | Tesamorelin | 8.0 | 10mg | 10.1mg | +1.0% | 99.90% | Lab E |
| 23 May 2026 | Andarine (S-4) Raw | 4.0 | 10g | 11.2g | +11.8% | 99.42% | Lab A |
| 23 May 2026 | Cerebrolysin | 7.4 | 10mg | 9.2mg | -7.7% | 96.09% | Lab B |
| 23 May 2026 | Retatrutide 30mg Pen Kit | 4.0 | 20mg | 18.1mg | -9.3% | 97.88% | Lab A |
| 21 May 2026 | EPO | 5.3 | 10mg | 12.4mg | +24.0% | 98.71% | Lab G |
| 21 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.4 | 5mg | 4.8mg | -3.0% | 96.34% | Lab A |
| 21 May 2026 | Tamoxifen (Nolvadex) Raw | 5.5 | 500g | 511.7g | +2.3% | 99.46% | Lab G |
| 21 May 2026 | Glutathione | 6.0 | 5mg | 4.9mg | -1.1% | 96.18% | Lab G |
| 20 May 2026 | Drostanolone Propionate (Mast P) Raw | 5.4 | 5g | 5.4g | +8.0% | 99.72% | Lab F |
| 20 May 2026 | Selank | 5.6 | 10mg | 12.3mg | +23.1% | 96.20% | Lab A |
| 19 May 2026 | Tirzepatide | 7.8 | 10mg | 10.2mg | +2.0% | 99.80% | Lab G |
| 19 May 2026 | Retatrutide | 7.8 | 15mg | 16.6mg | +10.7% | 99.70% | Lab G |
| 19 May 2026 | Adipotide | 8.1 | 15mg | 16.7mg | +11.1% | 97.96% | Lab E |
| 19 May 2026 | Anavar (Oxandrolone) Raw | 6.0 | 5g | 4.3g | -13.5% | 98.70% | Lab E |
| 19 May 2026 | MENT (Trestolone Acetate) | 6.7 | 100mg/ml | 95.9mg/ml | -4.1% | 95.57% | Lab C |
| 19 May 2026 | Selank 10mg + Semax 10mg Blend | 4.9 | 30mg | 27.8mg | -7.2% | 96.22% | Lab F |
| 19 May 2026 | SLU-PP-332 | 4.5 | 10mg | 9.0mg | -10.0% | 97.76% | Lab B |
| 19 May 2026 | YK11 | 5.6 | 10mg | 10.6mg | +6.3% | 96.44% | Lab G |
| 17 May 2026 | Retatrutide | 6.8 | 10mg | 11.4mg | +14.0% | 99.50% | Lab G |
| 17 May 2026 | PE 22-28 | 4.1 | 20mg | 17.3mg | -13.5% | 98.75% | Lab B |
| 17 May 2026 | Tesofensine | 6.4 | 20mg | 19.2mg | -4.1% | 98.23% | Lab F |
| 17 May 2026 | Thymosin Alpha-1 | 6.6 | 10mg | 11.5mg | +14.6% | 99.13% | Lab A |
| 29 Jan 2026 | Glutathione | 6.0 | 2mg | 2.1mg | +4.7% | 95.77% | Lab G |
| 29 Jan 2026 | Primobolan E Raw | 7.5 | 10g | 11.0g | +9.8% | 96.29% | Lab B |
| 29 Jan 2026 | Selank 10mg + Semax 10mg Blend | 5.3 | 15mg | 14.2mg | -5.3% | 99.14% | Lab G |
| 26 Jan 2026 | Retatrutide | 7.3 | 5mg | 5.22mg | +4.4% | 99.60% | Lab E |
| 26 Jan 2026 | Adipotide | 6.3 | 2mg | 2.1mg | +6.8% | 97.37% | Lab D |
| 26 Jan 2026 | MT-1 | 6.4 | 10mg | 9.6mg | -3.5% | 99.87% | Lab E |
| 26 Jan 2026 | Selank | 7.5 | 10mg | 9.8mg | -1.6% | 96.89% | Lab D |
| 26 Jan 2026 | Test Suspension | 5.7 | 200mg/ml | 236.0mg/ml | +18.0% | 99.48% | Lab G |
| 19 Jan 2026 | Tesamorelin | 8.0 | 10mg | 10.1mg | +1.0% | 99.95% | Lab E |
| 19 Jan 2026 | Andarine (S-4) Raw | 4.6 | 100g | 112.2g | +12.2% | 96.52% | Lab B |
| 19 Jan 2026 | Lipo-C 120mg | 6.3 | 300mg/ml | 357.8mg/ml | +19.3% | 96.85% | Lab A |
| 19 Jan 2026 | SLU-PP-332 | 5.6 | 50mg | 54.6mg | +9.2% | 98.04% | Lab F |
| 19 Jan 2026 | Thymosin Alpha-1 | 6.1 | 15mg | 16.0mg | +6.8% | 95.42% | Lab C |
| 15 Jan 2026 | Tirzepatide | 3.2 | 10mg | 13mg | +30.0% | 99.17% | Lab E |
| 9 Jan 2026 | Chonluten | 4.0 | 30mg | 36.9mg | +23.2% | 98.51% | Lab B |
| 9 Jan 2026 | LGD-4033 (Ligandrol) | 5.9 | 100mg | 107.5mg | +7.5% | 98.16% | Lab C |
| 9 Jan 2026 | MOTS-C | 6.7 | 30mg | 37.4mg | +24.7% | 96.50% | Lab D |
| 7 Jan 2026 | ACE-031 | 4.0 | 30mg | 36.2mg | +20.7% | 99.51% | Lab E |
| 7 Jan 2026 | Chonluten | 6.6 | 30mg | 36.4mg | +21.2% | 97.65% | Lab G |
| 7 Jan 2026 | Superdrol Oil | 7.6 | 300mg/ml | 257.6mg/ml | -14.1% | 95.40% | Lab F |
| 7 Jan 2026 | Testosterone Base Micro Raw | 7.6 | 5g | 5.6g | +11.0% | 95.61% | Lab C |
| 7 Jan 2026 | Vesugen | 5.5 | 5mg | 4.3mg | -13.7% | 99.31% | Lab E |
| 7 Jan 2026 | Vesugen | 5.5 | 20mg | 20.7mg | +3.3% | 96.95% | Lab C |
| 6 Jan 2026 | Hyaluronic acid | 7.4 | 20mg | 21.5mg | +7.4% | 95.21% | Lab E |
| 6 Jan 2026 | MOTS-C | 7.9 | 15mg | 17.7mg | +17.7% | 97.33% | Lab A |
| 6 Jan 2026 | MOTS-C | 6.3 | 20mg | 22.7mg | +13.5% | 95.16% | Lab F |
| 6 Jan 2026 | MT-1 | 4.6 | 20mg | 19.0mg | -4.9% | 97.11% | Lab E |
| 6 Jan 2026 | Retatrutide 30mg Pen Kit | 4.0 | 10mg | 10.2mg | +1.8% | 95.72% | Lab D |
| 6 Jan 2026 | Retatrutide 30mg Pen Kit | 4.8 | 5mg | 4.4mg | -12.7% | 95.47% | Lab A |
| 29 Dec 2025 | BPC157 10mg + TB500 10mg Blend | 4.9 | 50mg | 48.9mg | -2.2% | 96.61% | Lab A |
| 29 Dec 2025 | EPO | 5.7 | 50mg | 61.7mg | +23.5% | 98.25% | Lab G |
| 29 Dec 2025 | Tesofensine | 6.6 | 10mg | 12.5mg | +24.7% | 99.96% | Lab E |
| 12 Dec 2025 | ACE-031 | 6.4 | 5mg | 4.4mg | -12.2% | 95.74% | Lab C |
| 12 Dec 2025 | Anavar (Oxandrolone) Raw | 5.8 | 100g | 124.6g | +24.6% | 96.80% | Lab D |
| 12 Dec 2025 | MT-1 | 4.3 | 5mg | 5.4mg | +8.8% | 97.11% | Lab F |
| 12 Dec 2025 | Primobolan E Raw | 7.8 | 1g | 1.0g | -1.3% | 95.33% | Lab A |
| 12 Dec 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 8.9 | 10mg | 12.4mg | +23.6% | 96.72% | Lab F |
| 12 Dec 2025 | Sildenafil (Viagra) | 7.4 | 20mg | 23.2mg | +16.1% | 96.45% | Lab B |
| 12 Dec 2025 | Superdrol Oil | 6.5 | 300mg/ml | 297.1mg/ml | -1.0% | 97.17% | Lab F |
| 23 Nov 2025 | Hyaluronic acid | 9.0 | 15mg | 17.5mg | +16.3% | 97.62% | Lab C |
| 23 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.8 | 15mg | 13.7mg | -8.8% | 98.32% | Lab C |
| 23 Nov 2025 | Superdrol Oil | 8.7 | 200mg/ml | 178.5mg/ml | -10.7% | 96.51% | Lab E |
| 23 Nov 2025 | Test Suspension | 6.3 | 200mg/ml | 222.0mg/ml | +11.0% | 95.18% | Lab G |
| 23 Nov 2025 | Vesugen | 6.3 | 50mg | 62.0mg | +24.0% | 98.97% | Lab B |
| 17 Nov 2025 | Adipotide | 5.8 | 15mg | 18.7mg | +24.9% | 95.28% | Lab E |
| 17 Nov 2025 | Lipo-C 120mg | 4.5 | 200mg/ml | 237.1mg/ml | +18.6% | 98.90% | Lab A |
| 17 Nov 2025 | Retatrutide 30mg Pen Kit | 4.0 | 20mg | 17.3mg | -13.5% | 99.65% | Lab A |
| 14 Nov 2025 | Lipo-C 120mg | 7.3 | 100mg/ml | 90.5mg/ml | -9.5% | 99.81% | Lab G |
| 5 Nov 2025 | Adipotide | 7.6 | 20mg | 21.6mg | +7.8% | 95.91% | Lab C |
| 5 Nov 2025 | Primobolan E Raw | 4.1 | 500g | 579.0g | +15.8% | 98.57% | Lab G |
| 5 Nov 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 9.3 | 50mg | 48.0mg | -3.9% | 97.97% | Lab G |
| 5 Nov 2025 | Test Suspension | 7.7 | 200mg/ml | 197.6mg/ml | -1.2% | 95.06% | Lab G |
| 4 Nov 2025 | GHRP-6 Acetate | 5.8 | 20mg | 21.4mg | +6.8% | 99.92% | Lab G |
| 4 Nov 2025 | Glutathione | 6.2 | 10mg | 11.6mg | +15.9% | 99.06% | Lab E |
| 4 Nov 2025 | MENT (Trestolone Acetate) | 5.9 | 200mg/ml | 197.1mg/ml | -1.5% | 98.03% | Lab F |
| 4 Nov 2025 | Sildenafil (Viagra) | 5.3 | 20mg | 17.4mg | -12.8% | 98.85% | Lab C |
| 4 Nov 2025 | Tesofensine | 6.0 | 100mg | 119.3mg | +19.3% | 97.79% | Lab C |
| 4 Nov 2025 | Thymosin Alpha-1 | 5.6 | 15mg | 15.8mg | +5.4% | 96.07% | Lab B |
| 17 Oct 2025 | Hyaluronic acid | 6.5 | 2mg | 2.2mg | +8.2% | 99.18% | Lab G |
| 17 Oct 2025 | Selank | 5.2 | 5mg | 4.9mg | -2.0% | 95.95% | Lab E |
| 17 Oct 2025 | Sildenafil (Viagra) | 7.4 | 100mg | 100.8mg | +0.8% | 99.69% | Lab F |
| 17 Oct 2025 | SLU-PP-332 | 5.5 | 50mg | 59.9mg | +19.8% | 96.12% | Lab B |
| 17 Oct 2025 | Superdrol Oil | 6.8 | 200mg/ml | 191.6mg/ml | -4.2% | 98.65% | Lab E |
| 9 Oct 2025 | Anavar (Oxandrolone) Raw | 6.2 | 1g | 0.9g | -12.0% | 97.48% | Lab B |
| 9 Oct 2025 | BPC157 10mg + TB500 10mg Blend | 4.0 | 30mg | 26.0mg | -13.4% | 97.36% | Lab C |
| 3 Oct 2025 | ACE-031 | 4.2 | 30mg | 27.3mg | -9.1% | 95.30% | Lab C |
| 3 Oct 2025 | EPO | 5.2 | 30mg | 27.5mg | -8.4% | 95.36% | Lab E |
| 3 Oct 2025 | HGH Fragment 176-191 | 6.9 | 20mg | 19.7mg | -1.6% | 99.18% | Lab C |
| 3 Oct 2025 | KPV Oral | 4.0 | 10mg | 10.7mg | +6.8% | 98.64% | Lab F |
| 3 Oct 2025 | LGD-4033 (Ligandrol) | 5.3 | 50mg | 61.5mg | +23.0% | 98.79% | Lab B |